Our data showed a trend indicating that patients of a higher biological age were more likely to discontinue AMA therapy.
← all excerpts
Factors Associated with Survival and Discontinuation of Anti-Malarial Agents in Systemic Lupus Erythematosus: Results from a Tertiary Swedish Referral Centre.
1
—
—